Experiences - CRU-GLOBAL

CRU Global Experiences

Over the past decade, CRU-GLOBAL’s proprietary clinical sites have successfully conducted more than 350 trials, demonstrating our operational excellence and commitment to quality. In collaboration with our extensive network of partner sites, including leading academic institutions and specialized clinics, we have collectively delivered thousands of clinical studies across a wide range of therapeutic areas.

Key Areas of Expertise at CRU-Global Sites
in Early Phase (Phase I and IIa) studies:

Phase 1 Trials: Specializing in studies involving healthy volunteers, patients with hepatic and renal impairment, drug-drug interaction (DDI) studies, and first-in-human trials.

CNS Studies: Expertise in conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, and ALS.

Oncology Studies: Our leading partner sites specialize in pulmonary oncology, while both our own sites and an extensive partner network are engaged in conducting comprehensive basket trials across a broad range of oncology indications.

Key Areas of Expertise at CRU-Global Sites
in Later Phase studies (Phase II and III) :

Ready to speak
with Us?